Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO
Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare […]
Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Axol Bioscience, a leading pluripotent stem cell technology provider for drug discovery has signed an […]
XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer
XNK Therapeutics today announced the appointment of Hugo Petit as Chief Financial Officer (CFO) and […]
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics
Bayer AG is joining forces with Acuitas Therapeutics, a biotechnology company specializing in the development […]
Abivax Appoints Ida Hatoum as Chief People Officer
Abivax SA, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the […]
Eureka Therapeutics Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer
Eureka Therapeutics, a clinical-stage biotechnology company developing novel T-cell therapies to treat cancer, today announced […]
Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors
Kallyope, a clinical-stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with […]
BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
BioCentriq, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today […]
NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries
NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch […]
Marie Mazur Appointed Chair of PharmaJet Board of Directors
PharmaJet, a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more